SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-029742
Filing Date
2022-10-28
Accepted
2022-10-27 18:00:55
Documents
101
Period of Report
2022-07-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1810154
2 ex10-22.htm EX-10.22 15232
3 ex10-23.htm EX-10.23 11987
4 ex10-24.htm EX-10.24 83972
5 ex10-25.htm EX-10.25 167273
6 ex10-26.htm EX-10.26 53998
7 ex31-1.htm EX-31.1 17066
8 ex31-2.htm EX-31.2 17196
9 ex32-1.htm EX-32.1 6553
10 ex32-2.htm EX-32.2 7225
11 ex10-22_001.jpg GRAPHIC 3237
12 ex10-23_002.jpg GRAPHIC 1813
13 ex10-23_001.jpg GRAPHIC 3016
14 ex10-25_001.jpg GRAPHIC 3084
15 img_003.jpg GRAPHIC 206443
16 img_004.jpg GRAPHIC 144096
17 sym_001.jpg GRAPHIC 800
18 img_011.jpg GRAPHIC 115536
19 fin_002.jpg GRAPHIC 2510
20 ex10-22_002.jpg GRAPHIC 6828
21 ex10-24_001.jpg GRAPHIC 3236
22 ex10-24_006.jpg GRAPHIC 7697
23 GRAPHIC form10-k_002.jpg GRAPHIC 2348
  Complete submission text file 0001493152-22-029742.txt   9205209

Data Files

Seq Description Document Type Size
24 XBRL SCHEMA FILE bctx-20220731.xsd EX-101.SCH 62904
25 XBRL CALCULATION FILE bctx-20220731_cal.xml EX-101.CAL 59591
26 XBRL DEFINITION FILE bctx-20220731_def.xml EX-101.DEF 273819
27 XBRL LABEL FILE bctx-20220731_lab.xml EX-101.LAB 459079
28 XBRL PRESENTATION FILE bctx-20220731_pre.xml EX-101.PRE 368291
95 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1095292
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 001-40101 | Film No.: 221338443
SIC: 2834 Pharmaceutical Preparations